__timestamp | Lantheus Holdings, Inc. | Ligand Pharmaceuticals Incorporated |
---|---|---|
Wednesday, January 1, 2014 | 125519000 | 55402000 |
Thursday, January 1, 2015 | 135522000 | 66107000 |
Friday, January 1, 2016 | 137780000 | 103402000 |
Sunday, January 1, 2017 | 162135000 | 135736000 |
Monday, January 1, 2018 | 174885000 | 245116000 |
Tuesday, January 1, 2019 | 174811000 | 108935000 |
Wednesday, January 1, 2020 | 138761000 | 156000000 |
Friday, January 1, 2021 | 187695000 | 214957000 |
Saturday, January 1, 2022 | 581703000 | 143418000 |
Sunday, January 1, 2023 | 709543000 | 96265000 |
In pursuit of knowledge
In the competitive landscape of the pharmaceutical industry, understanding financial performance is crucial. This analysis delves into the gross profit trends of Lantheus Holdings, Inc. and Ligand Pharmaceuticals Incorporated from 2014 to 2023. Over this period, Lantheus Holdings has demonstrated a remarkable growth trajectory, with its gross profit increasing by approximately 465%, peaking in 2023. In contrast, Ligand Pharmaceuticals experienced a more volatile journey, with a notable peak in 2018, followed by fluctuations, ultimately leading to a 61% decrease by 2023. This divergence highlights Lantheus Holdings' strategic advancements and market adaptability, while Ligand Pharmaceuticals faces challenges in maintaining consistent growth. Such insights are invaluable for investors and stakeholders aiming to make informed decisions in the ever-evolving pharmaceutical sector.
Eli Lilly and Company and Lantheus Holdings, Inc.: A Detailed Gross Profit Analysis
AstraZeneca PLC and Ligand Pharmaceuticals Incorporated: A Detailed Gross Profit Analysis
Gross Profit Analysis: Comparing Pfizer Inc. and Lantheus Holdings, Inc.
Gross Profit Comparison: Amgen Inc. and Ligand Pharmaceuticals Incorporated Trends
Bristol-Myers Squibb Company and Lantheus Holdings, Inc.: A Detailed Gross Profit Analysis
Walgreens Boots Alliance, Inc. vs Ligand Pharmaceuticals Incorporated: A Gross Profit Performance Breakdown
Lantheus Holdings, Inc. and Corcept Therapeutics Incorporated: A Detailed Gross Profit Analysis
Key Insights on Gross Profit: Lantheus Holdings, Inc. vs Perrigo Company plc
Lantheus Holdings, Inc. and Arrowhead Pharmaceuticals, Inc.: A Detailed Gross Profit Analysis
Key Insights on Gross Profit: Lantheus Holdings, Inc. vs Vericel Corporation
Gross Profit Trends Compared: Vericel Corporation vs Ligand Pharmaceuticals Incorporated
Key Insights on Gross Profit: Ligand Pharmaceuticals Incorporated vs MiMedx Group, Inc.